“Borisovskiy Zavod Medicinskikh Preparatov” JSC “Borisovskiy Zavod Medicinskikh Preparatov” JSC.

Slides:



Advertisements
Similar presentations
KRK Group consists of experts in the area of Law, Finance, Marketing and Information Technologies, having deep knowledge and significant experience in.
Advertisements

Geography Review Russia & the Former Soviet Union.
FINEST S.p.A. 20 YEARS OF EXPERIENCE OVERSEAS 500 DEALS APPROVED 270 MLN € TOTAL INVESTMENTS AMOUNT.
makfa.ru Chelyabinsk pasta factory is instituted Technologies are updated quality- wise: new packaging materials, foreign-made packaging equipment and.
Russian-Eurasian Republics Sixth Grade Social Studies Mr. Zahn F.R. Dantzler, Educator.
State – Equity Concern « Uzpharmsanoat » Welcomes guests and participants of Uzbek-U.S.A Business Forum “ Investment Opportunities of the pharmaceutical.
Institute of Management and Rural Development INTAS Research Project on Agri-food Industry Restructuring in Ukraine and Moldova (AFIRUM)
Public Procurement in Transition Countries: Major Trends in Provision of Access to Justice 16 July 2014 UNCITRAL Standards for Transparency, Accountability.
Our Achievements. The Winner of International Award.
Business cooperation for business peolple! CJSC Holding “Pinskdrev”
Erasmus Mundus November 20, Erasmus Mundus – Programme objectives: Promote European quality offer in higher education.
For veterinary medicines A brief introduction…
Slide 1 Summary of responses on multidimensional poverty measurement (Eastern Europe, Caucasus and Central Asia) UNECE 4 May 2015.
Corporate Presentation J.B.Chemicals & Pharmaceuticals Ltd.
Meeting on Environmental Assessments Geneva, 16-17April 2013 Items of the provisional agenda.
Salimov A.H. Chairman of the Association of Food Industry enterprises Investment potential of Food Industry of the Republic of Uzbekistan.
Joint Stock Company “Uzbuildmaterials” Tashkent, May 2012.
Aranskaya Str., 6, Minsk Belarus, tel.: (+37517) ; PRESENTATION Investments In The Food Industries of The Republic.
Investment project of Ferghana plant of chemical fiber Olim F. Maksudov Director General.
Investment project of KINAP Open Joint Stock Company Mr. Refat Gafarov Deputy Director General CK.
INFORMATION ABOUT THE INVESTMENT PROJECT “The production engineering of the reducer gear drive high pressure fuel pump for complete set of JSC “KAMAZ”
Trade (and migration) issues in Central Asia Ben Slay Senior advisor UNDP Regional Bureau for Europe and CIS Geneva, 7 May
Challenges and Opportunities of Georgia’s Economy Mr. Aleksi Aleksishvili ₋ Chairman of Policy and Management Consulting Group (PMCG) ₋
2010 December Kazyna Capital Management Kazakhstan fund of funds Corporate presentation.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
“Pipe plant “Profil-Akras” named after Makarov V.V." - the manufacturer of steel water - and gas electrowelded pipes and square, rectangular, oval and.
“Only measurable things exist” Max Planck Group of company "Turbulentnost-Don"
Investment project of ONIKS Joint Stock Company Mr. Abubakir Uskenbaev Deputy Director General.
UNIDO Energy Development and Cleaner Production Programmes In Europe and NIS Grzegorz Donocik Chief Europe and NIS Programme Vienna Economic.
Czech – UNDP Trust Fund March 2007 Emerging Donors Workshop in Budapest Hana Kosová (UNDP Regional Centre Bratislava, Programme Associate to the Czech.
JSC «DBK – Leasing» Subsidiary of JSC «Development Bank of Kazakhstan» Аstana, 2009.
222515, Svetlaya Roshcha settlement, Borisov district, Minsk region, the Republic of Belarus phone/fax Internet:
What is an immigrant? An immigrant is a person who moves from one country or region to another in order to make a new home. Picture from:
 IWBAT analyze Vietnam songs  IWBAT describe the end of the Cold War.
The investment capacity of the Leather Industry of Uzbekistan and the prospects of investment cooperation.
Reinsurance solutions and demands: actual within FSU Dmitry GARMASH Deputy CEO, Ph.D., MBA Unity Re Ltd.
Migration Statistics Global database United Nations Economic Commission for Europe (UNECE) and United Nations Population Fund (UNFPA) Istanbul, Turkey,
Valentina Botan Post-soviet countries: the journey from resource- driven economies to knowledge based-economies. Focus on ICT sector ICT Education R&D.
Interstate Statistical Committee of the Commonwealth of Independent States (CIS-STAT) On the implementation of the Project “ Program of personnel training.
Europe Research PowerPoint Each group (2-3) must choose two countries from Europe and create a PPT that teaches their classmates about those nations.
Project Coordinators Meeting, 15th & 16th March 2010 TEMPUS IV- SECOND CALL FOR PROPOSALS RESULTS.
Discussion on key issues, challenges and progress made Olim Latipov Consultant to the UNECE Secretariat 4 November 2013.
Current situation on conducting international comparison of the GDP and purchasing power parities of the CIS countries for 2004.
State Stock Company «Uzpharmsanoat» “ Investment capacity of pharmaceutical industry and prospects of investment cooperation ”
Lifelong Learning Programme GRUNDTVIG Multilateral networks INTEGRA- Migrants' Integrating Kit Workshop, January, 2011 The Republic of Belarus in the System.
BANKIZATION OF RUSSIA AND ECONOMIC GROWTH Garegin Tosunyan Liechtenstein July 2, 2007.
Russia and the Republics. Russia is Huge! Climate.
O.Rudnytskyi, O.Gladun Demographic losses of Ukraine and other republics of the former Soviet Union in the Second World War Ptoukha Institute for Demography.
Population Dynamics in Eastern Europe and Central Asia and development agenda Marta Diavolova, Programme Adviser, EECA RO, UNFPA Regional Conference The.
Political Boundary Change: U.S.S.R. Human Geography B Ms. Weigel & Mrs. Houser Human Geography B Ms. Weigel & Mrs. Houser.
COMMONWEALTH OF INDEPENDENT STATES BY: B. HART. WHAT IS THE COMMONWEALTH OF INDEPENDENT STATES? The Commonwealth of Independent States is a confederation.
Nearly 70 licences have been issued to pharmaceutical enterprises in Georgia up to date. However, only about ten of them have real manufacturing facilities.
Shareholders of the bank Licenses and certificates Joint-Stock Commercial “Aloqabank” was founded under the Resolution of the Cabinet of Ministers of the.
MULTI-CULTURAL EDUCATION IN THE MURMANSK REGION: PROBLEMS AND PERSPECTIVES Alexandra Burtseva, PhD in Pedagogy, Murmansk State Humanities University.
1 Profitable and reliable business with ELAMED years in the market of medical products. 25 years in the market of medical products. Yelatma Instrument-Making.
TB Europe Coalition Civil society guide to EU funding Prepared by: Rachael Crockett.
2016. Abdi Ibrahim Global Pharm LLP  Pharmaceutical plant for production of medicines in accordance with the GMP standards of the Republic of Kazakhstan.
АК «Узфармсаноат» About the pharmaceutical industry of Uzbekistan and possible areas of cooperation with pharmaceutical companies of Great Britain
Welcome to Vityas Company.
پنل نگاهی به جایگاه ایران در صادرات گیاهان دارویی، فرآورده های طبیعی و سنتی و بررسی مسائل و چالش های آن دکتر بی بی مهشید حایری زاده معاون اداره کل نظارت.
Migration from Central Asian countries, гг. (mille).
JSC «DBK – Leasing» Subsidiary of JSC «Development Bank of Kazakhstan»
March 1st, 2017 Learning Target: I will be able to identify how the Cold War effected the world and US relations Literacy Target: To gain general knowledge.
وضعیت بیماری سل در جهان، منطقه و ایران
بیماری سل TUBERCULOSIS
What is immigration? Immigration is the movement of people from
Cumulative reported HIV infections per million population
Nuclear Age Continues Cold War evolved over 4 decades
Power of States.
AN ALTERNATIVE APPROACH Aleksandar Medjedovic
Presentation transcript:

“Borisovskiy Zavod Medicinskikh Preparatov” JSC “Borisovskiy Zavod Medicinskikh Preparatov” JSC

Brief view Pharmaceutical factory Joint Stock Company “Borisovskiy Zavod Medicinskikh Preparatov” is the leading manufacture and the exporter of broad-spectrum drugs in the Republic of Belarus. The factory was established in The company town of “Borisovskiy Zavod Medicinskikh Preparatov” JSC is above 11 hectares. Total employment at the factory is 2700 persons. Production volume in the actual prices for 2013 – billion rubles (103.3 million USD) Now JCS “Borisovskiy Zavod Medicinskikh Preparatov” is a modern dynamically developing pharmaceutical factory with new technology and high quality production and skilled personal. slide 1 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

Brief view JSC “ BZMP” holds participating shares in the companies: slide 2 “Borisovskiy Zavod Medicinskikh Preparatov” JSC Belarus- German JV Fresenius-Borisov- Dialysetechnik (JV “FREBOR” OOO) Participating shares of JSC “BZMP” – 78.2% OOO “Borisov KZ” (Kazakhstan) Participating shares of JSC “BZMP”– 30% BORIMED LTD (Kyrgyzstan) Participating shares of JSC “BZMP”– 50% OOO “Boripharm” (RF) Participating shares of JSC “BZMP”– 100% “Borisovskiy Zavod Medicinskikh Preparatov” JSC

slide 3 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

Brief view The core business of “Borisovskiy Zavod Medicinskikh Preparatov” JSC Ampoule production and powder for injections in vials (antibiotics) tablet production production of liquid photochemical and soft medical drugs production of hard capsule drugs slide 4 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

Production volume in the actual prices in ,8 billions rubles, in 2013 – 917,3 billion rubles (103,3 million USD). Production volume in comparable prices Billions rubles / growth rate to the previous year Billons rubles Short summary slide 5 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

slide 6 “Borisovskiy Zavod Medicinskikh Preparatov” JSC Production pattern for 2013

Export pattern Republic of Belarus Russian Federation Kazakhstan Uzbekistan Tajikistan Turkmenistan Kyrgyzstan Ukraine Moldova Armenia Latvia Lithuania Estonia Azerbaijan Georgia Afghanistan USA Iraq Somalia Yemen Lebanon Macedonia Production was exported to 24 regions including CIS countries, Russia, nearby and foreign countries. Vietnam DPRK EGYPT slide 7 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

Portion of JSC “BZMP” in total domestic production of medical drugs for 2013 (million packs) BZMP JSC keeps 36% of sales of medical drugs sold by domestic in the Republic of Belarus (on the basis of quantities). slide 8 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

slide 9 “Borisovskiy Zavod Medicinskikh Preparatov” JSC Portion of BZMP JSC in total sales of medical drugs in the Republic of Belarus for 2013 (million packs) BZMP JSC keeps 26% for sales of medical drugs in the Republic of Belarus (on the basis of quantities)

Export pattern Export ratio (%) in total volume exports for 2013, thousand USD In 2013 export of production amounted to 55.4 million USD. slide 10 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

slide 11 “Borisovskiy Zavod Medicinskikh Preparatov” JSC Volume of export In 2013 export volume amounts to 55.4 million US dollars or % of the corresponding period last year.

TOP - 10 of medical drugs Rating placeName Sales volume for 2013 (local sales + export) In thousand USD 1 Valeriane extract, coated tablets 20 mg, № Acetylsalicylic acid, tablets 500 mg № Ceftriaxone, powder for injections, 1 g Analgin 50% № Citramon-Borimed, tablets № Sodium chloride, 0,9% solution for injections, 5ml № Cefazolin, powder for injections, 1 g Folic acid, tablets № Lidocaine, solution for injections 2 ml Cyanocobalamin, solution for injections 1502 slide 12 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

DEALERS NET “Borisovskiy Zavod Medicinskikh Preparatov”JSC № п/п Country Number of dealers 1 Kazakhstan 23 2 Russian Federation 10 3 Uzbekistan 10 4 Moldova 11 5 Georgia 7 6 Azerbaijan 7 7 Other foreign countries 14 8 Turkmenistan 4 9 Kyrgyzstan 3 10 Tajikistan 5 11 Ukraine 2 12 Armenia 2 Total 9898 Structure of dealer net slide 13 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

New medical drugs Name of drugPharmacologic 2009 Zovasticor, tabl.Hypolipemic (lowers the level of cholesterol in the blood) Chloropiramin, sol. for ing.Antihistamine preparation, inhibitor of H1- histamine receptors Lidocaine, sol. for ing.For solution of cephalosporin antibiotics of III generation Spasmatone, sol. for ing., tablAnalgesics and antispasmodics, non-narcotic Ketozoral, tabl.Anti-fungous Roxitromicyn – Borimed, tabl.Antibiotic macrolide 2010 Borinem, sol. for ing.Antibiotic carbopenem Aspicard, tabl.Non-steroidal anti-inflammatory drugs – acetilsalicylic acid Lansazole, caps.Inhibitor of proton pump BoriVit, sol. for ing.Hypoglycemic means, decreases sugar in blood Klindacil, sol. for ing.Antibiotic lincosamides group 2011 Lizinopril-Borimed,tabl.Inhibitor ACE (arterial hypertension, chronicle heart dysfunction) Ribavirin-Borimed, caps. Intivirus preparation Metformin-Borimed, tabl.For hypoglycemia treatment, per oral use, group Biguanid Risperidon-Borimed, tabl.Antipsychotic Sulpirid, caps.Antipsychotic Sedative dropsCombined sedative preparation “Borisovskiy Zavod Medicinskikh Preparatov” JSC

New medical drugs New medical drugs New medical drugs Name of drug Pharmacologic 2012 Metromizol-Dent, gel combined antimicrobial agent for dentistry use Gliclazide, tabl.2 nd generation sulfonylurea antidiabetic agent Clindacyl, caps.lincosamide antibiotic Clarithromycin, tabl.macrolide antibiotic Bisoprolol, tabl.hypotensive, antiarrythmic and antianginal remedy Ondansetron, tabl.antiemetic agent Ethambutol, tabl.antituberculous remedy Choline Alfascerate, sol. for inj. nootropic agent slide 15 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

“Borisovskiy Zavod Medicinskikh Preparatov” JSC New medical drugs New medical drugs New medical drugs Name of drug Pharmacologic 2013 Valerianae Forte, tabl.sedative and soporific Wite tablet, tabl.enterosorbent additional source of dietary fiber ProctoMaz ointment agent for the treatment of hemorrhoids Meloxicam, tabl.non-steroidal anti-inflammatory drug Magnekard,tabl.platelet aggregation inhibitors slide 16

Sales volume pattern in the Republic of Belarus for 2013 Increase of sales for 2013(compared to 2012) : Total increase of sales for 2013 – 130,7% (compared to 2012) Amounts to billion rubles ( 49.0 mln. USD) slide 17 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

Implementation of international standards All main production sectors have GMP certificate and monitored in accordance with the quality standards of GMP. The factory was certified with: Quality and Operational Health and Safety Management Quality Management Systems for medical drugs and biologically active additives conformity STB ISO Environment Management Systems for production and sales of medical drugs (ecological certificate) STB ISO 14001:2005 Occupational Health & Safety System Certification for production and sale of medical drug and biologically active additives - STB Certificate of Conformity for Production of Valeriane extract tablets accordingly to the EC standards issued by Latvian Certification Centre. slide 18 “Borisovskiy Zavod Medicinskikh Preparatov” JSC

“Borisovskiy Zavod Medicinskikh Preparatov” JSC Award of the government of the Republic of Belarus Award of government of the Republic of Belarus in the field quality 2011 is awarded to open joint stock company ‘Borisovskiy Zavod Medicinskikh Preparatov”. The company is awarded for its high efficient quality management and assurance of production of quality competitive products. slide 19

Proposal on cooperation slide 20 “Borisovskiy Zavod Medicinskikh Preparatov” JSC We offer to create a joint venture on the basis of existing sites of JSC “BZMP”: 1. Joint venture for production of solutions for injections in ampoules Collective investment fund – 45.5 mln USD Participant’s quotas: JSC “BZMP” – 25.5 mln USD – 56.0% Investor – 20.0 mln USD – 44.0% JSC “BZMP”: a)hands over its existing production sites and equipment for production of solutions for injections in ampoules; b)hands over the whole range of products in the form of solutions for injections. Investor: a)pays the cost of the reconstruction of ampoule production; b)offers a new range of medical products.

“Borisovskiy Zavod Medicinskikh Preparatov” JSC Proposal on cooperation 2. Joint venture for production of medical products in the form of tablets Collective investment fund – 23.2 mln USD Participant’s quotas: JSC “BZMP” – 8.2 mln USD – 35.4% Investor – 15.0 mln USD – 64.6% JSC “BZMP”: a)hands over a part of its existing production sites and equipment for production of medical products in the form of tablets; b)hands over a part of the range of products in the form of tablets. Investor: a)pays the cost of the reconstruction of existing tablet production; b)offers a new range of medical products. We invite you for cooperation! slide 21

Health, the dearest value is trusted to us ! slide 22 “Borisovskiy Zavod Medicinskikh Preparatov” JSC